Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Name: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Published: 2025
License: Public Domain

Alliance for Clinical Trials in Oncology · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

castration-sensitive prostate carcinoma, metastatic prostate adenocarcinoma, stage ivb prostate cancer ajcc v8, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Related documents